NioLeads 
Taysha Gene Therapies
Biotechnology · Dallas, Texas, United States · 99 Employees
Who is Taysha Gene Therapies
Taysha Gene Therapies is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. With a singular focus on developing transformative medicines, Taysha aims to address severe unmet medical needs and dramatically improve the lives of patients and their caregivers. The Company’s management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing process and a clinically and commercially proven AAV9 capsid in an effort to rapidly translate treatments from bench to bedside.
Company Information
Website
Industry
Employees
99
Address
Frequently Asked Questions regarding Taysha Gene Therapies
Where is Taysha Gene Therapies based?
Taysha Gene Therapies is based in Dallas, Texas, United States.
What industry does Taysha Gene Therapies belong to?
Taysha Gene Therapies is in the industry of: Biotechnology
How many employees does Taysha Gene Therapies have?
99 peoples are employed at Taysha Gene Therapies
What is Taysha Gene Therapies's official website?
Taysha Gene Therapies official website is
http://www.tayshagtx.com
What are Taysha Gene Therapies social media links?
Taysha Gene Therapies
LinkedIn
page
